Rekom Biotech

🌍 Chagas Disease: A Growing Concern in Warmer Months

Did you know that Chagas disease, caused by the Trypanosoma cruzi parasite, becomes more prevalent during the summer in the Southern Hemisphere? With rising temperatures in endemic regions, the need for early and accurate diagnosis is more critical than ever—especially for vulnerable groups like pregnant women and immunocompromised patients. 🩺

Timely detection can prevent complications, protect unborn children, and ensure better outcomes for immunosuppressed individuals. At Rekom Biotech, we’re committed to advancing healthcare with reliable diagnostic tools to combat infectious diseases like Chagas.

👉 Discover how our solutions are making a difference: https://shorturl.at/NVM0P.

Let’s raise awareness and take action together. 💪

Chagas - Rekom Biotech IVD reagents for diagnosis of Chagas caused by Trypanosoma cruzi

🎉 Exciting News from Rekombiotech! 🎉
We are thrilled to announce that we've been awarded a grant for the development of advanced chemiluminescence immunoassays designed specifically for high-throughput testing in blood banks. 🩸✨

This milestone marks a significant step toward revolutionizing diagnostic efficiency and ensuring faster, more reliable results for blood banks worldwide. 🚀

Read more about this exciting development here 👇.

Thank you for supporting innovation in biotechnology! 🌟

Government Invests Over €1.8 Million in Four R&D&I Projects in Andalusia - Rekom Biotech Government Invests Over €1.8 Million in Four R&D&I Projects in Andalusia

🌍 International Day of Epidemic Preparedness 🌍

We would like to join the global community in recognizing the importance of preparedness in the face of potential epidemics. At Rekom Biotech, we are proud to support the development of high-quality IVD diagnostic kits by supplying the raw materials that ensure fast, accurate, and reliable results. 🧪💉

By working alongside manufacturers of diagnostic kits, we are contributing to a future where the world is better equipped to handle health crises swiftly and effectively.

Together, we can ensure that healthcare systems worldwide are ready for whatever comes next.

🔬 Preparedness begins with innovation.

"

🌟 Unlocking the Future of Recombinant Protein Production 🌟

Choosing the right expression system doesn’t have to be overwhelming—it’s all about finding the perfect fit for your protein’s needs. 💡

At Rekom Biotech, we’ve perfected the use of Escherichia coli and Pichia pastoris for efficient, cost-effective protein production. But now, we’re leveling up! 🚀

✅ Introducing Baculovirus Systems: A game-changer for producing complex proteins.
✅ Coming Soon – Mammalian Cells: The gold standard for proteins requiring human-like fidelity and post-translational modifications.

Why does it matter? Not all proteins are created equal, and the right expression system makes all the difference:
▪️ E. coli: Fast and affordable for simpler proteins.
▪️ Pichia pastoris: A powerhouse for larger, more complex proteins.
▪️ Insect Cells: Perfect for proteins needing intricate folding or glycosylation.
▪️ Mammalian Cells: Unmatched for therapeutic proteins with high precision.

🔬 We’re evolving to match your research needs. Which expression system do you use most often? And what do you think the future holds for recombinant protein production?

💬 Drop your thoughts in the comments—we’d love to hear from you!

P.S. Follow us to stay updated on how we’re expanding our capabilities in 2024 and beyond. Together, let’s drive innovation forward! 🌍

Expression systems for the production of recombinant proteins - Rekom Biotech Expression systems for the production of recombinant proteins.